Copyright
©The Author(s) 2016.
World J Gastrointest Oncol. Jun 15, 2016; 8(6): 509-519
Published online Jun 15, 2016. doi: 10.4251/wjgo.v8.i6.509
Published online Jun 15, 2016. doi: 10.4251/wjgo.v8.i6.509
Figure 1 Schematic drawing of genetic and molecular pathways predisposing to small bowel carcinoma.
Wnt: Wingless-type MMTV integration site family; KRAS: Kirsten rat sarcoma viral oncogene homolog; LOH: Loss of heterozygosity; CIMP: CpG island methylator phenotype; MSI: Microsatellite instability; BRAFV600E: V-raf murine sarcoma viral oncogenes homolog B; mTOR: Mammalian target of rapamycin; TGF-β: Transforming growth factor β; IL: Interleukin; CD4TL: CD4 T-lymphocytes.
- Citation: Shenoy S. Genetic risks and familial associations of small bowel carcinoma. World J Gastrointest Oncol 2016; 8(6): 509-519
- URL: https://www.wjgnet.com/1948-5204/full/v8/i6/509.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v8.i6.509